Treatment Effect According to Timing of Administration of DWP14012 40 mg

NCT04613895 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

186

Enrollment

INDUSTRY

Sponsor class

Conditions

Erosive Esophagitis

Interventions

DRUG: DWP14012
DRUG: DWP14012

Sponsor

Daewoong Pharmaceutical Co. LTD.

Collaborators

[object Object]